FAQ: Understanding the Rapid Spread of 'Nightmare Bacteria'
Summary
The article discusses the alarming increase in 'nightmare bacteria' cases in the U.S., which are characterized by antibiotic resistance, high mortality, and the ability to spread resistance to other bacteria. This growing crisis has prompted scientific research and corporate development of treatments to address this serious public health threat.
What are ’nightmare bacteria'?
Nightmare bacteria are a category of bacteria characterized by three deadly attributes: resistance to all or almost all antibiotics, high mortality levels, and the ability to spread antibiotic resistance to other types of bacteria.
Why are these bacteria called ’nightmare bacteria'?
They are called nightmare bacteria because of their triple threat of being resistant to most antibiotics, having high mortality rates, and being able to spread antibiotic resistance to other bacteria, making them extremely dangerous and difficult to treat.
When was the rise of nightmare bacteria first observed?
Former CDC director Tom Frieden observed rising cases of nightmare bacteria in 2013, and data shows that cases continue to increase at an alarming rate in the U.S.
Where is the spread of nightmare bacteria occurring?
According to the content, nightmare bacteria are increasing at an alarming rate specifically in the United States.
Who is involved in addressing this bacterial threat?
The scientific community is grappling with understanding and addressing this crisis, while for-profit companies like Soligenix Inc. (NASDAQ: SNGX) are focused on developing treatments for these bacteria.
What makes nightmare bacteria particularly dangerous?
Nightmare bacteria are particularly dangerous because they combine antibiotic resistance with high mortality rates and the ability to transfer that resistance to other bacteria, creating a compounding public health threat.
What is BioMedWire and how is it related to this topic?
BioMedWire is a specialized communications platform focused on biotechnology and biomedical sciences that published this article, providing information about the nightmare bacteria crisis and developments in treatment research.
How can I get more information about BioMedWire’s coverage?
You can visit https://www.BioMedWire.com for more information or text ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only) to receive SMS alerts from BioMedWire.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 241532